The GLP is committed to full transparency. Download and review our 2019 Annual Report

How Republicans and Democrats could work together to streamline biotech regulations

Screen Shot at PM
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

[Editor’s note: Greg Jaffe is director of the Project on Biotechnology at the Center for Science in the Public Interest.]

On March 9, 2017, the National Academy of Sciences released its report titled Preparing for Future Products of Biotechnology.

[T]here are several recommendations [in the report] that should receive bipartisan support….  If those recommendations are implemented, they would greatly improve the federal regulatory system for biotechnology products.

Screen Shot at PM
Greg Jaffe

One recommendation that should garner universal support is that “to enable effective regulation, it would be beneficial to have a single point of entry into the regulatory system.”  The current regulatory system for biotechnology products involves three different agencies—FDA, USDA, and EPA—and applies different statutes to different products.  Some products, such as a corn plant engineered to produce a biological pesticide, require separate reviews by three agencies.

With more biotechnology products expected in the next five to ten years than ever before, now is the time to make the necessary regulatory changes so that safe, new products can be marketed and their benefits can be realized by farmers, consumers, and the environment.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post: Biotech Blog: A Bipartisan Way Forward on Future Biotech Products

For more background on the Genetic Literacy Project, read GLP on Wikipedia

News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend